Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Cullen

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Transplantation|April 27, 2026
Evaluating the impact of neighborhood socioenvironmental burden on patient characteristics and survival in liver transplant recipientsSamar Semaan, Ashton A Connor, Sudha Kodali, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Scientific Reports|March 31, 2022
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progressionWilliam Gesztes, Cara Schafer, Denise Young, et al.
Cancer Medicine|May 31, 2022
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017Nathan Oehrlein, Samantha A Streicher, Huai-Ching Kuo, et al.
Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.
Genes & Cancer|February 14, 2017
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K GagAnshu Rastogi, Amina Ali, Shyh-Han Tan, et al.
JNCI Cancer Spectrum|February 8, 2023
Allostatic load and cardiovascular outcomes in males with prostate cancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JNCI Cancer Spectrum|August 8, 2024
Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort studyPriyanshu Nain, Nickolas Stabellini, Omar M Makram, et al.
Oncotarget|November 20, 2019
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies <i>ERG</i> as the strongest independent predictor of recurrenceWusheng Yan, Muhammad Jamal, Shyh-Han Tan, et al.
European Urology Focus|July 30, 2017
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient CohortJennifer Cullen, Denise Young, Yongmei Chen, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Transplantation|April 27, 2026
Evaluating the impact of neighborhood socioenvironmental burden on patient characteristics and survival in liver transplant recipientsSamar Semaan, Ashton A Connor, Sudha Kodali, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Scientific Reports|March 31, 2022
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progressionWilliam Gesztes, Cara Schafer, Denise Young, et al.
Cancer Medicine|May 31, 2022
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017Nathan Oehrlein, Samantha A Streicher, Huai-Ching Kuo, et al.
Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.
Genes & Cancer|February 14, 2017
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K GagAnshu Rastogi, Amina Ali, Shyh-Han Tan, et al.
JNCI Cancer Spectrum|February 8, 2023
Allostatic load and cardiovascular outcomes in males with prostate cancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JNCI Cancer Spectrum|August 8, 2024
Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort studyPriyanshu Nain, Nickolas Stabellini, Omar M Makram, et al.
Oncotarget|November 20, 2019
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies <i>ERG</i> as the strongest independent predictor of recurrenceWusheng Yan, Muhammad Jamal, Shyh-Han Tan, et al.
European Urology Focus|July 30, 2017
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient CohortJennifer Cullen, Denise Young, Yongmei Chen, et al.
Pageof 17